Saliva swab could revolutionise medical testing for millions
On behalf of the Organising Committee we would like to announce the Saliva Technology Application Research Symposium.
The inaugural Saliva Technology Application Research Symposium (STARS) brings the world’s best minds to Brisbane in July 2016 for Australia’s first major saliva conference detailing emerging research, translational and technological advances.
STARS 2016 will showcase emerging saliva research in Immunology, biosensors, innovation and salivary diagnostics. It will tackle the global challenges that face the sector through thought leadership and knowledge sharing.
Delegates will have opportunities for succession planning and road mapping. Innovations explored in the field include improved and customised diagnostic kits, e-health initiatives, in-home technology, cost-effective designs and processes and improving saliva stability and transportation.
This high calibre international scientific symposium will be a forum for the sharing of cutting edge research and showcasing clinical advancements in Saliva Research.
The Scientific Program will include:
- Saliva biomarker development
- Saliva diagnostics in cardiovascular disease and head and neck cancers
- Point of care/Rapid test applications
- Innovative saliva collection devices
- Saliva Rheology
- Chair-side diagnostics for dentistry
- Frugal innovation and constraint-driven innovation
- Innovation for the 21st century
- Think tank session on future directions for saliva research
We look forward to welcoming you to Brisbane in 2016.
Associate Professor Chamindie Punyadeera
|A/Prof. Punyadeera has had a hybrid research career working in industry as well as in academia. She has worked at Philips Electronics in the Netherlands and has been instrumental in developing Philips Mini-care I-20 for cardiac disease detection. She has also contributed to the development of an integrated platform to detect nucleic acids (Idylla TM) platform commercialised by Biocartis NV (Belgium). She is a globally acknowledged pioneer in salivary diagnostics. She is a consultant to Oasis Diagnostics®, USA and FLUIDS iQ™, Montreal, Canada. She has delivered plenary, keynote lecturers, and currently serve on the Editorial Board of the Journal of Oral Oncology. She leads a world-class saliva research laboratory at QUT, 12 researchers focusing on developing novel non-invasive diagnostic tools to detect heart disease and head and neck cancers early, linking oral health to systemic diseases. She is the convenor of the inaugural saliva conference in Australasia in 2016 and currently organising the second conference. She has >80 publications, 4 invited book chapters, cited 2533 times. She has also produced 15 PCT applications and has licensed salivary test for oral cancer to MDxHealth (USA). Her team is also develops prognostic assays to identify pateints likely to develop recurrences using circulating tumour cells. She has partnered with Clearbridge Biomedics in translating this prognostic assay into clinical practice. More...|
The key note speakers will include John Atherton (Royal Brisbane and Women’s Hospital, Australia), Vicki Clifton (Mater Research Institute – The University of Queensland, Australia), Jeff Craig (Murdoch Children’s Hospital, Australia), Paul Dastoor (University of Newcastle, Australia), Nevenka Dimitrova (Philips, USA), John Fraser (Prince Charles Hospital, Australia), Maree Gleeson (University of Newcastle, Australia), Wayne Leifert (CSIRO, Australia), Carolyn Mountford (Translational Research Institute, Australia), Chris Perry (Princess Alexandra Hospital, Australia), Shantha Rajaratnam (Monash University, Australia), Natalie Rickers (DNA Genotek), Jason Stokes (The University of Queensland, Australia), Zee Upton (Agency for Science, Technology and Research, Singapore), Laurence J. Walsh (Dental School, University of Queensland, Australia).